Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Line Conradsen Hiort"'
Autor:
Kristian Reich, Diamant Thaçi, Georg Stingl, Jens Strodl Andersen, Line Conradsen Hiort, Michala Oron Lexner, David Winkler, Carle Paul
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Brodalumab is approved for treatment of moderate-to-severe plaque psoriasis. Here, we assess the safety profile of brodalumab using pooled safety data from 5 phase II/III trials of brodalumab 140 mg or 210 mg. In total, 4,464 patients received brodal
Externí odkaz:
https://doaj.org/article/3c0b6f9114754154830dd2110ba85510
Publikováno v:
Médecine des Maladies Métaboliques. 11:64-71
Resume L’etude internationale de phase IV FullSTEP a compare, chez des patients diabetiques de type 2 mal controle, l’ajout progressif (APB) de bolus prandiaux d’insuline d’action rapide a un schema basal-bolus (BB). Apres 32 semaines, l’AP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ae3e503525b7d6f9c145728b71b2ae1
https://doi.org/10.1016/s1957-2557(17)30015-9
https://doi.org/10.1016/s1957-2557(17)30015-9
Autor:
Line Conradsen Hiort, Henning F. Andersen, Helena W. Rodbard, Virginia E. Visco, David H.W. Shu
Publikováno v:
Rodbard, H W, Visco, V E, Andersen, H, Hiort, L C & Shu, D H W 2014, ' Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study) : a randomised, treat-to-target clinical trial ', The Lancet Diabetes & Endocrinology, vol. 2, no. 1, pp. 30-7 . https://doi.org/10.1016/S2213-8587(13)70090-1
BACKGROUND: We compared stepwise addition of bolus insulin with a full basal-bolus regimen in patients with type 2 diabetes inadequately controlled on basal insulin plus oral antidiabetic drugs.METHODS: The FullSTEP study was a phase 4, 32-week, rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::991f971f4a774ffa30bbeb458be79116
https://doi.org/10.1016/s2213-8587(13)70090-1
https://doi.org/10.1016/s2213-8587(13)70090-1
Autor:
Valentina Alexandrovna Peterkova, Line Conradsen Hiort, Nandu Thalange, Lisbeth Bjerring Jensen, Abdullah Bereket
Publikováno v:
Diabetes Therapy
Background To study the long-term development (104 weeks) of insulin antibodies during treatment with insulin detemir (IDet) and insulin aspart (IAsp) in children with type 1 diabetes aged 2–16 years. Methods A 52-week, two-arm, randomized trial co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd3f9924541e97c2bd5002dbc40732ea
https://hdl.handle.net/11424/241380
https://hdl.handle.net/11424/241380
Autor:
Line Conradsen Hiort, Abdullah Bereket, Nandu Thalange, Valentina Alexandrovna Peterkova, Jens Larsen
Publikováno v:
Pediatric Diabetes. 12:632-641
This randomised (1:1), multinational, open-labelled, parallel group trial compared insulin detemir (IDet) with neutral protamine Hagedorn (NPH) insulin, in combination with mealtime insulin aspart, over 1 yr in subjects aged 2-16 yr with type 1 diabe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a7537a6a9bb7a86755f01ed18eba106
https://doi.org/10.1111/j.1399-5448.2010.00750.x
https://doi.org/10.1111/j.1399-5448.2010.00750.x
Autor:
Abdullah Bereket, Valentina Alexandrovna Peterkova, Line Conradsen Hiort, Jens Larsen, Nandu Thalange
Publikováno v:
Diabetic Medicine
Aims This 52-week, randomized, multinational, open-label, parallel-group, non-inferiority trial investigated the efficacy and safety of basalbolus treatment with insulin detemir vs. NPH (neutral protamine Hagedorn) insulin, in combination with insuli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::589b7cb7238d2c7c2ab0083432decb50
https://hdl.handle.net/11424/245462
https://hdl.handle.net/11424/245462
Autor:
David H.W. Shu, Line Conradsen Hiort, Helena W. Rodbard, Virginia E. Visco, Henning R. Andersen
Publikováno v:
Canadian Journal of Diabetes. 37:S43-S44
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6224d8ac54f678112b9d728cf50286f
https://doi.org/10.1016/j.jcjd.2013.08.125
https://doi.org/10.1016/j.jcjd.2013.08.125
Autor:
Radhakrishna Sothiratnam, Sultan Linjawi, Paturi Rao, Line Conradsen Hiort, Ramazan Sari, Henning F. Andersen
Publikováno v:
Linjawi, S, Sothiratnam, R, Sari, R, Andersen, H, Hiort, L C & Rao, P 2015, ' The study of once-and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial ', Primary care diabetes, vol. 9, no. 5, pp. 370-6 . https://doi.org/10.1016/j.pcd.2014.11.001
AIMS: Investigate efficacy and tolerability of intensifying diabetes treatment with once- or twice-daily biphasic insulin aspart 30 (BIAsp 30) added to sitagliptin, and twice-daily BIAsp 30 without sitagliptin in patients with type 2 diabetes (T2D) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::283f1e3244ede4ed033650bcc2f4760b
Autor:
Line Conradsen Hiort, Hanne Hollnagel, Volkert Siersma, Anni Brit Sternhagen Nielsen, Svend Kreiner, Thomas Drivsholm
Publikováno v:
University of Copenhagen
Aims: Self-rated general health (SRH) predicts future mortality. We examined all-cause mortality at 10, 20, and 29 years' follow-up and its association with SRH measured at the age of 40 years in a cohort of 1,198 healthy Danes born in 1936 and who w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfbd6b05fd884073d5ef8e785fb060c2
https://curis.ku.dk/portal/en/publications/selfrated-general-health-among-40yearold-danes-and-its-association-with-allcause-mortality-at-10-20-and-29-years-followup(31d0e3f0-f621-11dd-bf70-000ea68e967b).html
https://curis.ku.dk/portal/en/publications/selfrated-general-health-among-40yearold-danes-and-its-association-with-allcause-mortality-at-10-20-and-29-years-followup(31d0e3f0-f621-11dd-bf70-000ea68e967b).html
Autor:
Volkert Siersma, Hanne Hollnagel, Svend Kreiner, Lene Falgaard Eplov, Anni Brit Sternhagen Nielsen, Line Conradsen Hiort, Thomas Drivsholm
Publikováno v:
University of Copenhagen
Self-rated general health (SRH) predicts future mortality. SRH may change, and these changes may alter the mortality risk. All-cause mortality until the age of 68 and its association with changes in SRH from the age of 40-45, 45-51, and 51-60 years w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d53b85d5db3ba8b8d34385369515e6c5
https://curis.ku.dk/portal/en/publications/the-impact-of-changes-in-selfrated-general-health-on-28year-mortality-among-middleaged-danes(1cb8b020-64dd-11df-928f-000ea68e967b).html
https://curis.ku.dk/portal/en/publications/the-impact-of-changes-in-selfrated-general-health-on-28year-mortality-among-middleaged-danes(1cb8b020-64dd-11df-928f-000ea68e967b).html